Cramer Rosenthal Mcglynn LLC cut its stake in Universal Health Services, Inc. (NYSE:UHS) by 48.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 181,630 shares of the health services provider’s stock after selling 168,242 shares during the period. Cramer Rosenthal Mcglynn LLC’s holdings in Universal Health Services were worth $20,588,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors also recently made changes to their positions in UHS. Cerebellum GP LLC bought a new position in shares of Universal Health Services in the fourth quarter worth about $127,000. Crossmark Global Holdings Inc. bought a new position in shares of Universal Health Services in the third quarter worth about $205,000. Zeke Capital Advisors LLC bought a new position in shares of Universal Health Services in the third quarter worth about $228,000. IFM Investors Pty Ltd bought a new position in shares of Universal Health Services in the third quarter worth about $303,000. Finally, Advanced Asset Management Advisors Inc bought a new position in shares of Universal Health Services in the fourth quarter worth about $340,000. 87.57% of the stock is owned by institutional investors.
UHS has been the subject of several analyst reports. Zacks Investment Research cut shares of Universal Health Services from a “hold” rating to a “sell” rating in a research report on Saturday, January 6th. Wells Fargo & Co initiated coverage on shares of Universal Health Services in a research report on Tuesday, January 30th. They set an “outperform” rating and a $144.00 price target for the company. Credit Suisse Group reiterated an “outperform” rating and set a $135.00 price target (up previously from $125.00) on shares of Universal Health Services in a research report on Tuesday, December 19th. Citigroup upgraded shares of Universal Health Services from a “neutral” rating to a “buy” rating in a research report on Tuesday, December 12th. Finally, Goldman Sachs Group initiated coverage on shares of Universal Health Services in a research report on Wednesday, January 3rd. They set a “buy” rating and a $137.00 price target for the company. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and twelve have issued a buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $133.40.
Universal Health Services (NYSE:UHS) last issued its quarterly earnings data on Wednesday, February 28th. The health services provider reported $2.00 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.84 by $0.16. The firm had revenue of $2.64 billion during the quarter, compared to analysts’ expectations of $2.64 billion. Universal Health Services had a net margin of 7.23% and a return on equity of 15.06%. The business’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.80 earnings per share. equities analysts forecast that Universal Health Services, Inc. will post 9.56 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 15th. Investors of record on Thursday, March 1st will be issued a dividend of $0.10 per share. This represents a $0.40 dividend on an annualized basis and a yield of 0.32%. The ex-dividend date is Wednesday, February 28th. Universal Health Services’s dividend payout ratio is currently 5.12%.
Universal Health Services declared that its Board of Directors has initiated a share buyback plan on Wednesday, November 15th that permits the company to buyback $400.00 million in shares. This buyback authorization permits the health services provider to reacquire shares of its stock through open market purchases. Stock buyback plans are typically an indication that the company’s board believes its shares are undervalued.
ILLEGAL ACTIVITY WARNING: “Universal Health Services, Inc. (UHS) Shares Sold by Cramer Rosenthal Mcglynn LLC” was first posted by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of United States and international trademark and copyright law. The correct version of this piece of content can be read at https://sportsperspectives.com/2018/03/14/universal-health-services-inc-uhs-shares-sold-by-cramer-rosenthal-mcglynn-llc.html.
About Universal Health Services
Universal Health Services, Inc is a holding company. The Company’s principal business is owning and operating, through its subsidiaries, acute care hospitals and outpatient facilities, and behavioral healthcare facilities. The Company’s segments include Acute Care Hospital Services, Behavioral Health Services and Other.
Want to see what other hedge funds are holding UHS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Universal Health Services, Inc. (NYSE:UHS).
Receive News & Ratings for Universal Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Universal Health Services and related companies with MarketBeat.com's FREE daily email newsletter.